LC
BLFS icon

Lindbrook Capital’s BioLife Solutions BLFS Stock Holding History

Lindbrook Capital’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$2.19K Hold
96
– – ﹤0.01% 2254
2024
Q4 		$2.49K Hold
96
– – ﹤0.01% 2238
2024
Q3 		$2.4K Sell
96
-22
-19% -$520 ﹤0.01% 2285
2024
Q2 		$2.53K Buy
118
+22
+23% +$427 ﹤0.01% 2273
2024
Q1 		$1.78K Hold
96
– – ﹤0.01% 2281
2023
Q4 		$1.56K Buy
96
+58
+153% +$740 ﹤0.01% 2346
2023
Q3 		$525 Buy
+38
New +$599 ﹤0.01% 2524
2023
Q2 		– Sell
-74
Closed -$1.61K – 2729
2023
Q1 		$1.61K Sell
74
-15
-17% -$337 ﹤0.01% 2329
2022
Q4 		$1.62K Hold
89
– – ﹤0.01% 2333
2022
Q3 		$2K Buy
89
+54
+154% +$1.16K ﹤0.01% 1998
2022
Q2 		$0 Buy
35
+26
+289% +$382 ﹤0.01% 2500
2022
Q1 		$0 Hold
9
– – ﹤0.01% 2480
2021
Q4 		$0 Hold
9
– – ﹤0.01% 2079
2021
Q3 		$0 Hold
9
– – ﹤0.01% 1860
2021
Q2 		$0 Hold
9
– – ﹤0.01% 1913
2021
Q1 		$0 Hold
9
– – ﹤0.01% 1878
2020
Q4 		$0 Hold
9
– – ﹤0.01% 1779
2020
Q3 		$0 Buy
+9
New +$194 ﹤0.01% 1746

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Lindbrook Capital's BLFS Position: Q1 2025 in Review

Lindbrook Capital held its BioLife Solutions (BLFS) position steady in Q1 2025 at 96 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Lindbrook Capital first reported a position in BLFS in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.53K in Q2 2024. 188 funds tracked by Wall St. Rank hold BLFS as of Q1 2025.

  • Lindbrook Capital held 96 shares of BioLife Solutions worth $2.19K as of Q1 2025.
  • Lindbrook Capital left its BioLife Solutions share count unchanged in Q1 2025.
  • BioLife Solutions made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2254 holding.
  • Lindbrook Capital first reported a position in BioLife Solutions in Q3 2020 and has held it in 18 quarters since.
  • Lindbrook Capital's BioLife Solutions position peaked at $2.53K in Q2 2024.
  • 188 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.